Telehealth on the rise, page-1770

Yep everyone is concerned about this virus but the company is not going to give it away.
They are still working out how to integrate into platforms and then charge for it. We need to see money coming in the door, that’s how shareholders get value for our investment.

(Phenix and ResApp will work together under the JDA for the next three months to integrate ResAppDx-EU into Phenix’s telehealth app. During this time, ResApp and Phenix will negotiate the specifics of the fee-per-test payment model of using ResAppDx-EU on the Phenix App.)

Sure we are all in a hurry but the company is still taking baby steps...8 cents per share, remember.